Incremental Cost-Effectiveness of 13-valent Pneumococcal Conjugate Vaccine for Adults Age 50 Years and Older in the United States
Crossref DOI link: https://doi.org/10.1007/s11606-016-3651-0
Published Online: 2016-03-14
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stoecker, Charles
Kim, Lindsay
Gierke, Ryan
Pilishvili, Tamara
Text and Data Mining valid from 2016-03-14